痛风患者高尿酸血症之治疗Therapyforhyperuricemiaingout.ppt
《痛风患者高尿酸血症之治疗Therapyforhyperuricemiaingout.ppt》由会员分享,可在线阅读,更多相关《痛风患者高尿酸血症之治疗Therapyforhyperuricemiaingout.ppt(32页珍藏版)》请在咨信网上搜索。
1、痛風患者高尿酸血症之治療痛風患者高尿酸血症之治療(Therapy for hyperuricemia in goutTherapy for hyperuricemia in gout)主題選取的考量主題選取的考量常見的疾病常見的疾病高盛行率高盛行率醫療花費增加醫療花費增加臨床治療標準不一臨床治療標準不一國際已有治療指引國際已有治療指引主題選取的考量主題選取的考量常見的疾病常見的疾病高盛行率高盛行率資料來源:資料來源:PubMedPubMedKeyword:Hyperuricemia in TaiwanKeyword:Hyperuricemia in Taiwan1616篇篇 since 196
2、8 to 2004since 1968 to 2004主題選取的考量主題選取的考量常見的疾病常見的疾病高盛行率高盛行率Chang HY,Pan WH,Yeh WT,Tsai KS.Chang HY,Pan WH,Yeh WT,Tsai KS.Hyperuricemia and gout in Taiwan:results from the Hyperuricemia and gout in Taiwan:results from the Nutritional and Health Survey in Taiwan(1993-96).Nutritional and Health Survey
3、in Taiwan(1993-96).J Rheumatol.2001 Jul;28(7):1640-6.J Rheumatol.2001 Jul;28(7):1640-6.Population:2754 males and 2953 females aged 4 Population:2754 males and 2953 females aged 4 years and older years and older The prevalence of hyperuricemia in aboriginal The prevalence of hyperuricemia in aborigin
4、al males and femalesmales and females:5050 尿酸值尿酸值 年齡年齡男性男性 7.7 mg/dl 女性女性 6.6 mg/dl 19y/o26 17 45y/o22 23 主題選取的考量主題選取的考量常見的疾病常見的疾病高盛行率高盛行率Lai SW,Tan CK,Ng KC.Lai SW,Tan CK,Ng KC.Epidemiology of hyperuricemia in the elderly.Epidemiology of hyperuricemia in the elderly.Yale J Biol Med.2001 May-Jun;74(
5、3):151-7.Yale J Biol Med.2001 May-Jun;74(3):151-7.TimeTime:1998 May1998 MayPopulationPopulation:586(66%Men&34%Women)586(66%Men&34%Women)mean age was 73.1+/-5.3 mean age was 73.1+/-5.3 years years The proportions of hyperuricemia The proportions of hyperuricemia:(p .01)(p 416.5 Hyperuricemia was defi
6、ned as uric acid 416.5 micromol/l(7 mg/dl)in boys and 357 micromol/l(6 micromol/l(7 mg/dl)in boys and 357 micromol/l(6 mg/dl)in girls mg/dl)in girls Ninety of 224 girls(40.2%)and 56 of 190 boys Ninety of 224 girls(40.2%)and 56 of 190 boys(29.5%)were hyperuricemic.(29.5%)were hyperuricemic.主題選取的考量主題選
7、取的考量常見的疾病常見的疾病高盛行率高盛行率CHOU Chungtei CHOU Chungtei 周昌德周昌德 Hyperuricemia and gout among Taiwan Aborigines and Hyperuricemia and gout among Taiwan Aborigines and Taiwanese-prevalence and risk factors Taiwanese-prevalence and risk factors Chin Med J 2003;116(7):965-967 Chin Med J 2003;116(7):965-967 The
8、 prevalence of hyperuricemia and gout in The prevalence of hyperuricemia and gout in Atayal Aborigines to be 41.4%and 11.7%,Atayal Aborigines to be 41.4%and 11.7%,respectively.respectively.27%to 45%of aboriginal boys and 13%to 41%of 27%to 45%of aboriginal boys and 13%to 41%of aboriginal girls had hy
9、peruricemia.aboriginal girls had hyperuricemia.KinmenKinmen:the prevalence of hyperuricemia in men the prevalence of hyperuricemia in men was 25.8%(391/1515)was 25.8%(391/1515)through more than 6 years of follow-ups on 223 through more than 6 years of follow-ups on 223 asymptomatic hyperuricemic pat
10、ients,the 5-year asymptomatic hyperuricemic patients,the 5-year cumulative incidence of onset of gout was 18.8%cumulative incidence of onset of gout was 18.8%(42/223).The incidence increased with three(42/223).The incidence increased with three different baseline levels of uric acid,from different b
11、aseline levels of uric acid,from 10.8%(7.010.8%(7.0 uric aciduric acid8.0),to 27.7%(8.08.0),to 27.7%(8.0uric uric acid 9.0),to 61.6%(uric acidacid 9.0),to 61.6%(uric acid9.0).9.0).主題選取的考量主題選取的考量國際已有治療指引國際已有治療指引資料庫:資料庫:PubMedPubMedKeyword:Hyperuricemia guideline Keyword:Hyperuricemia guideline 8 8篇,篇
12、,since 1996 to 2003since 1996 to 20031:Meyers OL,Cassim B,Mody GM.Hyperuricaemia 1:Meyers OL,Cassim B,Mody GM.Hyperuricaemia and gout:clinical guideline 2003.S Afr Med J.and gout:clinical guideline 2003.S Afr Med J.2003 Dec;93(12 Pt 2):961-71.2003 Dec;93(12 Pt 2):961-71.2:Nakajima H,Matsuzawa Y.Intr
13、oduction of the 2:Nakajima H,Matsuzawa Y.Introduction of the new guideline for the management of hyperuricemia new guideline for the management of hyperuricemia and gout with special reference to its policy and gout with special reference to its policy Nippon Rinsho.2003 Jan;61 Suppl 1:442-9.Nippon
14、Rinsho.2003 Jan;61 Suppl 1:442-9.3:Tatsuno I,Saito Y.Hyperuricemia and 3:Tatsuno I,Saito Y.Hyperuricemia and atherosclerosis Nippon Rinsho.2003 Jan;61 Suppl atherosclerosis Nippon Rinsho.2003 Jan;61 Suppl 1:259-65.Review.1:259-65.Review.主題選取的考量主題選取的考量國際已有治療指引國際已有治療指引4:Nakajima H.Definition and deter
15、mination of 4:Nakajima H.Definition and determination of serum uric acid level Nippon Rinsho.2003 Jan;61 serum uric acid level Nippon Rinsho.2003 Jan;61 Suppl 1:154-7.Suppl 1:154-7.5:Nakajima H.Management of hyperuricemia in 5:Nakajima H.Management of hyperuricemia in occupational health:with refere
16、nce to guidelines occupational health:with reference to guidelines for the management of hyperuricemia and gout for the management of hyperuricemia and gout Sangyo Eiseigaku Zasshi.2003 Jan;45(1):12-9.Sangyo Eiseigaku Zasshi.2003 Jan;45(1):12-9.Review.Japanese.Review.Japanese.6:Gorter KJ,Romeijnders
17、 AC.The standard 6:Gorter KJ,Romeijnders AC.The standard hyperuricemia from the Dutch Family Physician;hyperuricemia from the Dutch Family Physician;reaction from rheumatology and general medicine reaction from rheumatology and general medicine Ned Tijdschr Geneeskd.2002 May 4;146(18):872;Ned Tijdsc
18、hr Geneeskd.2002 May 4;146(18):872;author reply 872-3.Dutch.author reply 872-3.Dutch.7:Chalmers J.Role of diuretics in the 7:Chalmers J.Role of diuretics in the treatment of hypertension:from large controlled treatment of hypertension:from large controlled trials to international guidelines Arch Mal
19、 trials to international guidelines Arch Mal Coeur Vaiss.1996 Sep;89 Spec No 4:39-43.Review.Coeur Vaiss.1996 Sep;89 Spec No 4:39-43.Review.French.French.8:Cummins D,Sekar M,Halil O,Banner N.8:Cummins D,Sekar M,Halil O,Banner N.Myelosuppression associated with azathioprine-Myelosuppression associated
20、 with azathioprine-allopurinol interaction after heart and lung allopurinol interaction after heart and lung transplantation.Transplantation.1996 Jun transplantation.Transplantation.1996 Jun 15;61(11):1661-2.15;61(11):1661-2.目前製作目前製作guidelineguideline之目的之目的台灣地區高尿酸血症的盛行率驚人,尤其施行成人健康體檢台灣地區高尿酸血症的盛行率驚人,尤
21、其施行成人健康體檢後,門診診療中常遇到病人詢問高尿酸血症該如何處理。而後,門診診療中常遇到病人詢問高尿酸血症該如何處理。而目前因無統一的目前因無統一的guidelineguideline可供依循,治療標準不一,常造可供依循,治療標準不一,常造成醫師及患者的困擾。期待檢視文獻後,能提供有用的資訊,成醫師及患者的困擾。期待檢視文獻後,能提供有用的資訊,建立使用降尿酸藥物之臨床底線,以為臨床診療之準則。建立使用降尿酸藥物之臨床底線,以為臨床診療之準則。臨床問題臨床問題1 1:無症狀之高尿酸血症需不需要治療?無症狀之高尿酸血症需不需要治療?資料來源:資料來源:PubMedPubMedKeyword:A
22、symtomatic hyperuricemia and treatment and Keyword:Asymtomatic hyperuricemia and treatment and review review 2323篇,篇,since 1977 to 2003since 1977 to 2003臨床問題臨床問題1 1:無症狀之高尿酸血症需不需要治療?無症狀之高尿酸血症需不需要治療?Dincer HE,Dincer AP,Levinson DJ.Asymptomatic Dincer HE,Dincer AP,Levinson DJ.Asymptomatic hyperuricemia
23、:to treat or not to treat.Cleve hyperuricemia:to treat or not to treat.Cleve Clin J Med.2002 Aug;69(8):594,597,600-2 passim.Clin J Med.2002 Aug;69(8):594,597,600-2 passim.Publication Types:Publication Types:ReviewReviewTreatment of asymptomatic hyperuricemia is not Treatment of asymptomatic hyperuri
24、cemia is not necessary in most patients,unless perhaps they have necessary in most patients,unless perhaps they have very high levels of uric acid or are otherwise at very high levels of uric acid or are otherwise at risk of complications,such as those with a personal risk of complications,such as t
25、hose with a personal or strong family history of gout,urolithiasis,or or strong family history of gout,urolithiasis,or uric acid nephropathy.uric acid nephropathy.臨床問題臨床問題1 1:無症狀之高尿酸血症需不需要治療?無症狀之高尿酸血症需不需要治療?Uhlig T.Gout and hyperuricaemia-should both be Uhlig T.Gout and hyperuricaemia-should both be
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 痛风 患者 尿酸 治疗 Therapyforhyperuricemiaingout
1、咨信平台为文档C2C交易模式,即用户上传的文档直接被用户下载,收益归上传人(含作者)所有;本站仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。所展示的作品文档包括内容和图片全部来源于网络用户和作者上传投稿,我们不确定上传用户享有完全著作权,根据《信息网络传播权保护条例》,如果侵犯了您的版权、权益或隐私,请联系我们,核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
2、文档的总页数、文档格式和文档大小以系统显示为准(内容中显示的页数不一定正确),网站客服只以系统显示的页数、文件格式、文档大小作为仲裁依据,平台无法对文档的真实性、完整性、权威性、准确性、专业性及其观点立场做任何保证或承诺,下载前须认真查看,确认无误后再购买,务必慎重购买;若有违法违纪将进行移交司法处理,若涉侵权平台将进行基本处罚并下架。
3、本站所有内容均由用户上传,付费前请自行鉴别,如您付费,意味着您已接受本站规则且自行承担风险,本站不进行额外附加服务,虚拟产品一经售出概不退款(未进行购买下载可退充值款),文档一经付费(服务费)、不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
4、如你看到网页展示的文档有www.zixin.com.cn水印,是因预览和防盗链等技术需要对页面进行转换压缩成图而已,我们并不对上传的文档进行任何编辑或修改,文档下载后都不会有水印标识(原文档上传前个别存留的除外),下载后原文更清晰;试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓;PPT和DOC文档可被视为“模板”,允许上传人保留章节、目录结构的情况下删减部份的内容;PDF文档不管是原文档转换或图片扫描而得,本站不作要求视为允许,下载前自行私信或留言给上传者【胜****】。
5、本文档所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用;网站提供的党政主题相关内容(国旗、国徽、党徽--等)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
6、文档遇到问题,请及时私信或留言给本站上传会员【胜****】,需本站解决可联系【 微信客服】、【 QQ客服】,若有其他问题请点击或扫码反馈【 服务填表】;文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“【 版权申诉】”(推荐),意见反馈和侵权处理邮箱:1219186828@qq.com;也可以拔打客服电话:4008-655-100;投诉/维权电话:4009-655-100。